A new blood screening test could help to identify ovarian cancer in its early stages when few symptoms are present, School of Medicine researchers reported in the May 10 issue of Proceedings of the National Academies of Sciences (PNAS).
Epithelial ovarian cancer is the leading cause of gynecologic cancer deaths in the United States and is three times more lethal than breast cancer. It is usually not diagnosed until its advanced stages and has come to be known as the "silent killer."
"Early diagnosis can help prolong or save lives, but clinicians currently have no sensitive screening method because the disease shows few symptoms," says the study's lead author Dr. Gil Mor, associate professor in the Department of Obstetrics, Gynecology & Reproductive Sciences.
Mor conducted the research with David Ward, deputy director of the Nevada Cancer Institute. They developed and tested a new blood test for ovarian cancer based on four proteins: leptin, prolactin, osteopontin and insulin-like growth factor-II. If the level of two or more of these biomarkers for a patient falls within a certain warning area, the test will predict that she has cancer. In a test group of over 200 ovarian cancer patients and healthy women, the test showed 95% sensitivity (fraction correctly diagnosed with cancer) and 95% specificity (fraction correctly diagnosed as cancer-free).
Each of the proteins had been previously suggested as a good cancer biomarker, though not as a set. In this study, no single protein could completely distinguish the cancer patients from the healthy controls.
Other authors on the study are Irene Visintin, Yinglei Lai, Hongyu Zhao, Dr. Peter Schwartz, Dr. Thomas Rutherford, Luo Yue and Patricia Bray-Ward.
-- By Karen Peart
T H I S
W E E K ' SS T O R I E S
Team creates blood test for 'silent killer'
University marks 100 years of 'Pomp and Circumstance'
Yale scientist featured in new stamp series
Twelve honored for strengthening town-gown ties
ENDOWED PROFESSORSHIPSTwo appointed to Sterling chairs
R. Howard Bloch: French and Medieval Studies
Ian Shapiro: Political science and YCIASRomano named Ruebhausen Professor
Waxman is appointed to Flaherty chair
Dr. State has been designated Harris Assistant Professor . . .
Krauss named to second term at Silliman
Researchers discover virus' potential to target and kill deadly brain tumor
Yale professors endow teaching and research fund in the history of science
Study shows, when it comes to fish genitalia, size has pros and cons
Two Yale scientists honored with election to the NAS
Six Yale affiliates elected fellows of scholarly society
Beijing conference explored Chinese constitutionalism
New scholarship will help nurture future activist ministers
Yale-IBM computer facility formally dedicated
REUNIONSAlumni will gather for talks, tours and other special events
Library exhibit celebrates the accomplishments of the Class of '55
Medical school reunions feature talks on cutting-edge research
Yale launches research on lung cancer . . .
Workshop will explore technology's power to capture . . .
Show features artist's colorful depictions of 'Northern Shores'
Glen Micalizio wins Beckman Young Investigator award . . .
IN MEMORIAMBenjamin Mordecai: Drama school teacher and Broadway producer
Memorial service to honor South African historian Leonard Thompson
Campus Notes
Bulletin Home|Visiting on Campus|Calendar of Events|In the News
Bulletin Board|Classified Ads|Search Archives|Deadlines
Bulletin Staff|Public Affairs|News Releases|
E-Mail Us|Yale Home